Highlights - This EHNS–ESMO–ESTRO Clinical Practice Guideline provides key recommendations for managing SCCHN. - It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. - Opportunities for personalised medicine in SCCHN are also discussed. - All recommendations were compiled by a multidisciplinary group of experts from different institutions and countries. - Recommendations are based on available clinical evidence and the collective expert opinion of the authors.
EHNS (Europeand Head and Neck Society) has over 3000 Members - Professionals of Head & Neck (Nurse, Oncologist, Radiotherapist, Surgeon,...) and beyond, in over European countries.
Current recommendations of the CEORL-HNS (Confederation of European Otorhinolaryngology - Head and Neck Surgery) about COVID-19. Access to the text here.
Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic
On January 30, 2020, the World Health Organization formally announced that the novel coronavirus disease (COVID-19) caused by SARS-CoV-2 is a worldwide health emergency. Subsequently, all National Health Systems and each medical center faced the exceptional... Continue reading. Oral Oncology - Volume 107, August 2020
News from National Societies
The European Head and Neck Society (EHNS): A True Multidisciplinary Platform for Head and Neck Oncology
In early 2006, the official documents to establish the European Head and Neck Society (EHNS) were signed by its founding Board in Brussels, Belgium. This is the final result of a road towards a true European multidisciplinary platform on head and neck tumours. It mirrors North American and other organisations and is endorsed by the International Federation of Head and Neck Oncologic Societies (IFHNOS). Herein we aim to bring this new organisation to the attention of the readers of ENT News.